Stabilin receptors clear LPS and control systemic inflammation

Summary: Lipopolysaccharides (LPSs) cause lethal endotoxemia if not rapidly cleared from blood circulation. Liver sinusoidal endothelial cells (LSEC) systemically clear LPS by unknown mechanisms. We discovered that LPS clearance through LSEC involves endocytosis and lysosomal inactivation via Stabil...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fatima Cabral, Mustafa Al-Rahem, John Skaggs, Thushara A. Thomas, Naresh Kumar, Qian Wu, Paolo Fadda, Lianbo Yu, John M. Robinson, Jonghan Kim, Ekta Pandey, Xinghui Sun, Wael N. Jarjour, Murugesan V.S. Rajaram, Edward N. Harris, Latha P. Ganesan
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/209b703b99394a00aadccb8cd283ebee
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:209b703b99394a00aadccb8cd283ebee
record_format dspace
spelling oai:doaj.org-article:209b703b99394a00aadccb8cd283ebee2021-11-20T05:10:07ZStabilin receptors clear LPS and control systemic inflammation2589-004210.1016/j.isci.2021.103337https://doaj.org/article/209b703b99394a00aadccb8cd283ebee2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2589004221013067https://doaj.org/toc/2589-0042Summary: Lipopolysaccharides (LPSs) cause lethal endotoxemia if not rapidly cleared from blood circulation. Liver sinusoidal endothelial cells (LSEC) systemically clear LPS by unknown mechanisms. We discovered that LPS clearance through LSEC involves endocytosis and lysosomal inactivation via Stabilin-1 and 2 (Stab1 and Stab2) but does not involve TLR4. Cytokine production was inversely related to clearance/endocytosis of LPS by LSEC. When exposed to LPS, Stabilin double knockout mice (Stab DK) and Stab1 KO, but not Stab2 KO, showed significantly enhanced systemic inflammatory cytokine production and early death compared with WT mice. Stab1 KO is not significantly different from Stab DK in circulatory LPS clearance, LPS uptake and endocytosis by LSEC, and cytokine production. These data indicate that (1) Stab1 receptor primarily facilitates the proactive clearance of LPS and limits TLR4-mediated inflammation and (2) TLR4 and Stab1 are functionally opposing LPS receptors. These findings suggest that endotoxemia can be controlled by optimizing LPS clearance by Stab1.Fatima CabralMustafa Al-RahemJohn SkaggsThushara A. ThomasNaresh KumarQian WuPaolo FaddaLianbo YuJohn M. RobinsonJonghan KimEkta PandeyXinghui SunWael N. JarjourMurugesan V.S. RajaramEdward N. HarrisLatha P. GanesanElsevierarticleBiological sciencesMolecular biologyImmune responseScienceQENiScience, Vol 24, Iss 11, Pp 103337- (2021)
institution DOAJ
collection DOAJ
language EN
topic Biological sciences
Molecular biology
Immune response
Science
Q
spellingShingle Biological sciences
Molecular biology
Immune response
Science
Q
Fatima Cabral
Mustafa Al-Rahem
John Skaggs
Thushara A. Thomas
Naresh Kumar
Qian Wu
Paolo Fadda
Lianbo Yu
John M. Robinson
Jonghan Kim
Ekta Pandey
Xinghui Sun
Wael N. Jarjour
Murugesan V.S. Rajaram
Edward N. Harris
Latha P. Ganesan
Stabilin receptors clear LPS and control systemic inflammation
description Summary: Lipopolysaccharides (LPSs) cause lethal endotoxemia if not rapidly cleared from blood circulation. Liver sinusoidal endothelial cells (LSEC) systemically clear LPS by unknown mechanisms. We discovered that LPS clearance through LSEC involves endocytosis and lysosomal inactivation via Stabilin-1 and 2 (Stab1 and Stab2) but does not involve TLR4. Cytokine production was inversely related to clearance/endocytosis of LPS by LSEC. When exposed to LPS, Stabilin double knockout mice (Stab DK) and Stab1 KO, but not Stab2 KO, showed significantly enhanced systemic inflammatory cytokine production and early death compared with WT mice. Stab1 KO is not significantly different from Stab DK in circulatory LPS clearance, LPS uptake and endocytosis by LSEC, and cytokine production. These data indicate that (1) Stab1 receptor primarily facilitates the proactive clearance of LPS and limits TLR4-mediated inflammation and (2) TLR4 and Stab1 are functionally opposing LPS receptors. These findings suggest that endotoxemia can be controlled by optimizing LPS clearance by Stab1.
format article
author Fatima Cabral
Mustafa Al-Rahem
John Skaggs
Thushara A. Thomas
Naresh Kumar
Qian Wu
Paolo Fadda
Lianbo Yu
John M. Robinson
Jonghan Kim
Ekta Pandey
Xinghui Sun
Wael N. Jarjour
Murugesan V.S. Rajaram
Edward N. Harris
Latha P. Ganesan
author_facet Fatima Cabral
Mustafa Al-Rahem
John Skaggs
Thushara A. Thomas
Naresh Kumar
Qian Wu
Paolo Fadda
Lianbo Yu
John M. Robinson
Jonghan Kim
Ekta Pandey
Xinghui Sun
Wael N. Jarjour
Murugesan V.S. Rajaram
Edward N. Harris
Latha P. Ganesan
author_sort Fatima Cabral
title Stabilin receptors clear LPS and control systemic inflammation
title_short Stabilin receptors clear LPS and control systemic inflammation
title_full Stabilin receptors clear LPS and control systemic inflammation
title_fullStr Stabilin receptors clear LPS and control systemic inflammation
title_full_unstemmed Stabilin receptors clear LPS and control systemic inflammation
title_sort stabilin receptors clear lps and control systemic inflammation
publisher Elsevier
publishDate 2021
url https://doaj.org/article/209b703b99394a00aadccb8cd283ebee
work_keys_str_mv AT fatimacabral stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT mustafaalrahem stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT johnskaggs stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT thusharaathomas stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT nareshkumar stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT qianwu stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT paolofadda stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT lianboyu stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT johnmrobinson stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT jonghankim stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT ektapandey stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT xinghuisun stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT waelnjarjour stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT murugesanvsrajaram stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT edwardnharris stabilinreceptorsclearlpsandcontrolsystemicinflammation
AT lathapganesan stabilinreceptorsclearlpsandcontrolsystemicinflammation
_version_ 1718419529784098816